Ascierto PA - Search Results

1

Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma.

Del Vecchio M, Di Guardo L, Ascierto PA, Grimaldi AM, Sileni VC, Pigozzo J, Ferraresi V, Nuzzo C, Rinaldi G, Testori A, Ferrucci PF, Marchetti P, De Galitiis F, Queirolo P, Tornari E, Marconcini R, Calabrò L, Maio M. Del Vecchio M, et al. Among authors: ascierto pa. Eur J Cancer. 2014 Jan;50(1):121-7. doi: 10.1016/j.ejca.2013.09.007. Epub 2013 Oct 4. Eur J Cancer. 2014. PMID: 24100024

2

Intermediate dose recombinant interferon-alpha as second-line treatment for patients with recurrent cutaneous melanoma who were pretreated with low dose interferon.

Ascierto PA, Daponte A, Parasole R, Perrone F, Caracò C, Melucci M, Palmieri G, Napolitano M, Mozzillo N, Castello G. Ascierto PA, et al. Cancer. 2000 Oct 1;89(7):1490-4. doi: 10.1002/1097-0142(20001001)89:7<1490::aid-cncr11>3.0.co;2-v. Cancer. 2000. PMID: 11013362 Clinical Trial.

3

Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.

Daponte A, Ascierto PA, Gravina A, Melucci MT, Palmieri G, Comella P, Cellerino R, DeLena M, Marini G, Comella G; Italian Cooperative Oncology Group. Daponte A, et al. Among authors: ascierto pa. Cancer. 2000 Dec 15;89(12):2630-6. Cancer. 2000. PMID: 11135225 Clinical Trial.

4

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies.

Ascierto PA, Scala S, Castello G, Daponte A, Simeone E, Ottaiano A, Beneduce G, De Rosa V, Izzo F, Melucci MT, Ensor CM, Prestayko AW, Holtsberg FW, Bomalaski JS, Clark MA, Savaraj N, Feun LG, Logan TF. Ascierto PA, et al. J Clin Oncol. 2005 Oct 20;23(30):7660-8. doi: 10.1200/JCO.2005.02.0933. J Clin Oncol. 2005. PMID: 16234528 Clinical Trial.

5

Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity.

Pagnanelli G, Bono R, Pizzichetta MA, Talamini R, Ascierto PA, Testori A, Stanganelli I; Italian Melanoma Intergroup (IMI). Pagnanelli G, et al. Among authors: ascierto pa. Anticancer Res. 2007 Jul-Aug;27(4C):2939-44. Anticancer Res. 2007. PMID: 17695474 Free article.

6

The Italian Network for Tumor Biotherapy (NIBIT): getting together to push the field forward.

Maio M, Nicolay HJ, Ascierto P, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Anzalone L, Fonsatti E, Parmiani G. Maio M, et al. J Transl Med. 2008 Feb 12;6:8. doi: 10.1186/1479-5876-6-8. J Transl Med. 2008. PMID: 18269750 Free PMC article.

7

Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16-18 October 2008.

Maio M, Nicolay HJ, Ascierto PA, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Fonsatti E, Parmiani G; NIBIT. Maio M, et al. Among authors: ascierto pa. Cancer Immunol Immunother. 2010 Jun;59(6):963-9. doi: 10.1007/s00262-009-0696-5. Epub 2009 Mar 28. Cancer Immunol Immunother. 2010. PMID: 19330329 Free PMC article. No abstract available.

8

Clinical genetic testing for familial melanoma in Italy: a cooperative study.

Bruno W, Ghiorzo P, Battistuzzi L, Ascierto PA, Barile M, Gargiulo S, Gensini F, Gliori S, Guida M, Lombardo M, Manoukian S, Menin C, Nasti S, Origone P, Pasini B, Pastorino L, Peissel B, Pizzichetta MA, Queirolo P, Rodolfo M, Romanini A, Scaini MC, Testori A, Tibiletti MG, Turchetti D, Leachman SA, Bianchi Scarrà G; IMI, Italian Melanoma Intergroup. Bruno W, et al. Among authors: ascierto pa. J Am Acad Dermatol. 2009 Nov;61(5):775-82. doi: 10.1016/j.jaad.2009.03.039. Epub 2009 Jun 4. J Am Acad Dermatol. 2009. PMID: 19500876

9

Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls.

Casula M, Alaibac M, Pizzichetta MA, Bono R, Ascierto PA, Stanganelli I, Canzanella S, Palomba G, Zattra E; Italian Melanoma Intergroup (IMI); Palmieri G. Casula M, et al. Among authors: ascierto pa. BMC Dermatol. 2009 Jul 22;9:7. doi: 10.1186/1471-5945-9-7. BMC Dermatol. 2009. PMID: 19624835 Free PMC article.

10

Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy.

Casula M, Muggiano A, Cossu A, Budroni M, Caracò C, Ascierto PA, Pagani E, Stanganelli I, Canzanella S, Sini M, Palomba G; Italian Melanoma Intergroup (IMI); Palmieri G. Casula M, et al. Among authors: ascierto pa. BMC Cancer. 2009 Oct 3;9:352. doi: 10.1186/1471-2407-9-352. BMC Cancer. 2009. PMID: 19799798 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

745 results

Search Page

Filters